Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$9,246
+$234 QoQ
Shares Held
59
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,543
of 1,603 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Capital Management Investments LLC holds $2,330,399 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
520 | $623,703 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
4,003 | $505,739 | |
| 3 | ABBV |
AbbVie Inc.
|
1,492 | $375,446 | |
| 4 | AMGN |
Amgen Inc
|
645 | $233,567 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,255 | $187,553 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,287 | $165,379 | |
| 7 | PFE |
Pfizer Inc
|
5,911 | $142,336 | |
| 8 | JNJ |
Johnson & Johnson
|
311 | $78,984 |
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,246 | 59 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $9,012 | 59 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,134 | 59 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,566 | 59 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,139 | 59 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $6,577 | 59 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $5,741 | 59 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $6,786 | 59 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $6,281 | 59 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $10,833 | 112 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $11,308 | 112 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,408 | 112 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||